NCT05705492
- Conditions
- Advanced Biliary Tract Carcinoma, Advanced Esophageal Carcinoma, Advanced Lung Carcinoma, +30 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Metastatic Colorectal Carcinoma (mCRC)
Explore clinical trials studying Metastatic Colorectal Carcinoma (mCRC). Study availability and eligibility vary by location and protocol.
8 public trials
4 recruiting studies
Metastatic Colorectal Carcinoma (mCRC) trial results
NCT07224724
- Conditions
- Colonic Diseases, Colorectal Cancer Liver Metastases (CRLM), Colorectal Neoplasms, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT07463599
- Conditions
- Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyposis Coli (APC) Gene Mutation, +21 more
- Locations
-
- Clinical Trials Nurse Navigator Scottsdale, Arizona, United States
NCT07043387
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +17 more
- Locations
-
- National Cancer Center Goyang-si, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance hospital Seoul, South Korea
Enrolling by Invitation
Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma
NCT07334587
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- Allama Iqbal Medical College, Lahore Lahore, Punjab Province, Pakistan
Not Yet Recruiting
A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
NCT07566897
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
- Locations
-
- Fondazione Policlinico Gemelli Unità di Fase 1: Unità di Farmacologia Clinica Roma, Italy
Not Yet Recruiting
OSCAR II STUDY - The ONCObind CTC Removal Study
NCT06655142
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer
NCT07150403
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- ICO Site Paul Papin Angers, France
- Les Bonnettes Arras, France
- Ght Unyon Auxerre Auxerre, France
- Bayeux Ch Bayeux, France